ORCL
60
-11
MU
50
3
WU
18
2
GE
65
8
SHW
61
3
MET
54
4
KSS
38
2
APD
55
-4
DFS
59
5
FE
39
-2
DTE
43
10
ZBH
44
-3
ROST
75
3
GS
60
-2
NWS
69
-4
SIG
47
4
AES
51
-4
RF
37
2
PRGO
37
-2
HSY
45
-3
ORCL
60
-11
MU
50
3
WU
18
2
GE
65
8
SHW
61
3
MET
54
4
KSS
38
2
APD
55
-4
DFS
59
5
FE
39
-2
DTE
43
10
ZBH
44
-3
ROST
75
3
GS
60
-2
NWS
69
-4
SIG
47
4
AES
51
-4
RF
37
2
PRGO
37
-2
HSY
45
-3
Financhill
Back

Algoma Central Vs. Spyre Therapeutics Industry Stock Comparison

Sell
33

ALC.TO
Algoma Central

Last Price:
14.16
Seasonality Move:
-1.47%
Sell
39

SYRE
Spyre Therapeutics

Last Price:
25.33
Seasonality Move:
49.76%
Sell
33
Algoma Central (ALC.TO) is a Sell

Is Algoma Central a Buy, Sell or Hold?

  • The current Algoma Central [ALC.TO] share price is $14.16. The Score for ALC.TO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ALC.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALC.TO Stock Price Chart

What is Algoma Central's stock price today?

  • The Algoma Central share price today is $14.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALC.TO is experiencing selling pressure, which indicates risk of future bearish movement.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $25.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

ALC.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 41.17 Sell
Chaikin Money Flow: -5911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.12 - 14.48) Sell
Bollinger Bands (100): (14.43 - 15.07) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 31.35 Sell
Chaikin Money Flow: -1780910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.05 - 37.75) Sell
Bollinger Bands (100): (27.4 - 39.18) Sell

ALC.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.2 Sell
20-day SMA: 14.23 Sell
50-day SMA: 14.51 Sell
200-day SMA: 14.78 Sell
8-day EMA: 14.19 Sell
20-day EMA: 14.26 Sell
50-day EMA: 14.45 Sell
200-day EMA: 14.83 Sell

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.63 Sell
20-day SMA: 34.16 Sell
50-day SMA: 35.1 Sell
200-day SMA: 24.22 Buy
8-day EMA: 32.34 Sell
20-day EMA: 33.91 Sell
50-day EMA: 34.32 Sell
200-day EMA: 27.18 Sell

Algoma Central Earnings Growth & ALC.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.38 per share, and an increase next year of $0.19 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

Algoma Central Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):